LEADER 03492nam  2200865   450 
001 9910693837603321
005 20221024210936.0
035   $a(CKB)3450000000002504
035   $a(NjHacI)993450000000002504
035   $a(CaOOCEL)244127
035   $a(OCoLC)56496308
035 9 $aocm56496308
035   $a(OCoLC)993450000000002504
035   $a(CaBNVSL)gtp00560975
035   $a(OCoLC)895541025
035   $a(VaAlCD)20.500.12592/nsfd07
035   $a(EXLCZ)993450000000002504
071 60$a244127$bCaOOCEL$q(Public Documents)
100   $a20221024d2004      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aIslet transplantation in patients with Type 1 diabetes mellitus /$fMargaret Piper, Jerome Seidenfeld and Naomi Aronson, editors
210  1$aRockville (MD) :$cAgency for Healthcare Research and Quality (US),$d[2004]
210  4$dİ2004
215   $a1 online resource (98 pages) $cillustrations
225 1 $aEvidence report/technology assessment ;$vno. 98
225 1 $aAHRQ publication ;$vno. 04-E 017-2
300   $aTitle from title screen (viewed on Sept. 13, 2004).
300   $a"August 2004."
320   $aIncludes bibliographical references.
327   $aAcknowledments -- Table of contents -- List of tables -- List of figures -- Abstract -- Re?sume -- Executive summary -- Sommaire -- Background -- Objectives -- Methods for literature review of effectiveness and safety of IT -- Methods for economic evaluation -- Results of literature review of effectiveness and safety of IT -- Results of economic evaluation -- Discussion -- Tables -- Figures -- References -- Appendices.
410  0$aMcGill University Health Centre Technology Assessment Unit report ;$vno. 66.
606   $aIslands of Langerhans$xTransplantation
606   $aDiabetes$xSurgery
606   $aIslets of Langerhans Transplantation
606   $aDiabetes Mellitus, Type 1$xtherapy
606   $aClinical medicine$2Iptcnc
606   $aComplications of diabetes mellitus$2Iptcnc
606   $aDiabetes management$2Iptcnc
606   $aDiabetes mellitus$2Iptcnc
606   $aDiabetes mellitus type 1$2Iptcnc
606   $aGlycated hemoglobin$2Iptcnc
606   $aHealth$2Iptcnc
606   $aHypoglycemia$2Iptcnc
606   $aInsulin$2Iptcnc
606   $aIslet cell transplantation$2Iptcnc
615  0$aIslands of Langerhans$xTransplantation.
615  0$aDiabetes$xSurgery.
615 12$aIslets of Langerhans Transplantation.
615 12$aDiabetes Mellitus, Type 1$xtherapy.
615  7$aClinical medicine
615  7$aComplications of diabetes mellitus
615  7$aDiabetes management
615  7$aDiabetes mellitus
615  7$aDiabetes mellitus type 1
615  7$aGlycated hemoglobin
615  7$aHealth
615  7$aHypoglycemia
615  7$aInsulin
615  7$aIslet cell transplantation
676   $a616.46206
702   $aPiper$b Margaret
702   $aSeidenfeld$b Jerome
702   $aAronson$b Naomi
712 02$aBlue Cross and Blue Shield Association.$bTechnology Evaluation Center.
712 02$aUnited States.$bAgency for Healthcare Research and Quality.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910693837603321
996   $aIslet transplantation in patients with Type 1 diabetes mellitus$93103403
997   $aUNINA